You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023260025
Dec 2023122011
Jan 20249308
Feb 20245603
Mar 202410204
Apr 20246205
May 202476011
Jun 20249907
Jul 2024112015
Aug 202411107
Sep 202484010
Oct 20247809
Nov 20248404
Dec 20247605
Jan 202566011
Feb 202554011
Mar 2025004
Apr 2025005
May 2025107
Jun 2025004
Total15360166